ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 635,08
0,23%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX
  6. NovaBay Pharmaceuticals Inc New (NBY)

  7. NovaBay Pharmaceuticals Inc New (NBY) Actualités

NBY

NovaBay Pharmaceuticals (NBY)

NovaBay Pharmaceuticals Inc New
De:
Trier par:
 Showing the most relevant articles for your search:AMEX:NBY
DateHeureSourceTitreSymboleSociété
31/05/202422h50Edgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
31/05/202422h43Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]AMEX:NBYNovaBay Pharmaceuticals Inc New
31/05/202403h31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:NBYNovaBay Pharmaceuticals Inc New
29/05/202423h22Business WireNovaBay Pharmaceuticals Announces Approval of All Proposals at its 2024 Annual Meeting of Stockholders and Provides Other Corporate UpdatesAMEX:NBYNovaBay Pharmaceuticals Inc New
13/05/202414h30Business WireNovaBay Pharmaceuticals Launches Avenova Product Bundles for Individualized Relief from Multifactorial Dry Eye SymptomsAMEX:NBYNovaBay Pharmaceuticals Inc New
09/05/202422h05Business WireNovaBay Pharmaceuticals Reports First Quarter 2024 Financial ResultsAMEX:NBYNovaBay Pharmaceuticals Inc New
07/05/202414h00Business WireNovaBay Pharmaceuticals Announces Record Ordered Product Sales of Avenova-Branded Products in April through AmazonAMEX:NBYNovaBay Pharmaceuticals Inc New
03/05/202412h50Business WireNovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024AMEX:NBYNovaBay Pharmaceuticals Inc New
22/04/202412h57Business WireNovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova SalesAMEX:NBYNovaBay Pharmaceuticals Inc New
20/04/202400h00Business WireNovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder EquityAMEX:NBYNovaBay Pharmaceuticals Inc New
17/04/202412h59Business WireNovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing ExpensesAMEX:NBYNovaBay Pharmaceuticals Inc New
26/03/202421h05Business WireNovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial ResultsAMEX:NBYNovaBay Pharmaceuticals Inc New
25/03/202423h38Business WireNovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024AMEX:NBYNovaBay Pharmaceuticals Inc New
14/03/202413h00Business WireNovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023AMEX:NBYNovaBay Pharmaceuticals Inc New
14/02/202420h52Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]AMEX:NBYNovaBay Pharmaceuticals Inc New
30/01/202415h00Business WireNovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in Avenova Unit Subscription-Based SalesAMEX:NBYNovaBay Pharmaceuticals Inc New
09/01/202415h15Business WireNovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma’s Extensive Distributor NetworkAMEX:NBYNovaBay Pharmaceuticals Inc New
04/01/202417h50Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesAMEX:NBYNovaBay Pharmaceuticals Inc New
06/12/202312h50Business WireNovaBay Pharmaceuticals Partners with Woo University to Educate Eyecare Professionals on the Use of Amniotic MembranesAMEX:NBYNovaBay Pharmaceuticals Inc New
09/11/202322h10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:NBYNovaBay Pharmaceuticals Inc New
09/11/202322h05Business WireNovaBay Pharmaceuticals Reports Third Quarter 2023 Financial ResultsAMEX:NBYNovaBay Pharmaceuticals Inc New
02/11/202311h50Business WireNovaBay Pharmaceuticals to Hold Third Quarter 2023 Conference Call on November 9, 2023AMEX:NBYNovaBay Pharmaceuticals Inc New
11/10/202314h00Business WireNovaBay Pharmaceuticals Expands Physician Dispensed Sales Channel with New Avenova ProgramsAMEX:NBYNovaBay Pharmaceuticals Inc New
02/10/202312h50Business WireNovaBay Pharmaceuticals to Present at the Dawson James Small Cap Growth ConferenceAMEX:NBYNovaBay Pharmaceuticals Inc New
21/09/202315h35GlobeNewswire Inc.Dawson James Securities Announces October Date for 8th Annual Small Cap Growth ConferenceAMEX:NBYNovaBay Pharmaceuticals Inc New
14/09/202314h00Business WireNovaBay Pharmaceuticals Announces Commercial Launch of Avenova® AllograftAMEX:NBYNovaBay Pharmaceuticals Inc New
11/09/202314h00Business WireNovaBay Pharmaceuticals Announces Agreement with BioStem Technologies to Commercialize Amniotic Tissue Allograft as Avenova® AllograftAMEX:NBYNovaBay Pharmaceuticals Inc New
10/08/202322h05Business WireNovaBay Pharmaceuticals Reports Second Quarter 2023 Financial ResultsAMEX:NBYNovaBay Pharmaceuticals Inc New
08/08/202322h05Business WireNovaBay Pharmaceuticals to Hold Second Quarter 2023 Conference Call on August 10, 2023AMEX:NBYNovaBay Pharmaceuticals Inc New
14/07/202314h30Business WireNovaBay Pharmaceuticals Reports Record Avenova Sales DayAMEX:NBYNovaBay Pharmaceuticals Inc New
 Showing the most relevant articles for your search:AMEX:NBY

Dernières Valeurs Consultées

USOTC
OCEHF
Oceania Healthcare (PK)
LSE
SR51
Hsbc Bk.27
DBI
DXXB
XJNZPPAU1C JPY INAV
EU
BE0001769232
Vlaamse Gemeenschap 1.39...
LSE
CHTR
GATE
CRBNUSDT
Carbon
BIT
P1HLG0
BNP Paribas Issuance
NYSE
PRG
PROG
BOV
BCWV39M
BlackRock Institutional ...
BIT
UC4ZGW
Unicredit Bank
NASDAQ
AUR
Aurora Innovations
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés